CSI Market
Sign In | Register

Comera Life Sciences Holdings Inc (CMRA) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access CMRA quarterly Cash Flow →
This cash flow overview for Comera Life Sciences Holdings Inc spans from to Dec 31 2022, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
12 Months
Operating Activities
Income-18.00
Depreciation & amortization0.09
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.14
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.38
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Non Cash Lease Expense0.00
Change In Fair Value Of Convertible Notes-
Reverse Recapitalization Issuance Costs In Excess Of Gross Proceeds6.57
Change In Fair Value Of Derivative Warrant Liabilities-2.01
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.03
Increase (Decrease) in Accounts Payable0.86
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities0.79
Increase (Decrease) in Security Deposits-0.01
Increase (Decrease) in Prepaid Expense and Other Assets0.80
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.65
Discontinued operations0.00
Net Cash flow from Operating Activities-9.77
Investing Activities
Capital Expenditures-0.03
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.03
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-1.06
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.49
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-5.05
Net Proceeds From Transaction And Private Placement3.31
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents6.56
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities5.24
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-9.80
Total Cash Flow-4.56
4 historic quarters locked

Sign in to unlock the full Comera Life Sciences Holdings Inc cash flow history.

Sign In Create Free Account

About Comera Life Sciences Holdings Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-23-062130

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License